|
|
Volumn 45, Issue 1-3, 2001, Pages 43-47
|
|
Proof of efficacy trials: Cross-over versus parallel-group
|
|
Author keywords
Cross over trials; Parallel group trials; Treatment period interaction
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
GABAPENTIN;
TOPIRAMATE;
ANTICONVULSANT THERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
CROSSOVER PROCEDURE;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
EPILEPSY;
HUMAN;
INTERMETHOD COMPARISON;
MEDICAL ETHICS;
MULTICENTER STUDY;
PARALLEL DESIGN;
PRIORITY JOURNAL;
ANTICONVULSANTS;
CLINICAL TRIALS;
CROSS-OVER STUDIES;
EPILEPSY;
HUMANS;
RESEARCH DESIGN;
|
|
EID: 0034918119
PISSN: 09201211
EISSN: None
Source Type: Journal
DOI: 10.1016/S0920-1211(01)00214-5 Document Type: Conference Paper |
|
Times cited : (31)
|
|
References (8)
|
